Financial reports
10-K
2023 FY
Annual report
5 Mar 24
10-Q
2023 Q3
Quarterly report
6 Nov 23
10-Q
2023 Q2
Quarterly report
8 Aug 23
10-Q
2023 Q1
Quarterly report
4 May 23
ARS
2022 FY
Annual report to shareholders
25 Apr 23
10-K
2022 FY
Annual report
2 Mar 23
10-Q
2022 Q3
Quarterly report
8 Nov 22
10-Q
2022 Q2
Quarterly report
11 Aug 22
10-Q
2022 Q1
Quarterly report
12 May 22
10-K
2021 FY
Annual report
10 Mar 22
Current reports
8-K
NeuroPace Announces Record Full Year 2023 Revenue of $65.4 Million
5 Mar 24
8-K
Departure of Directors or Certain Officers
7 Feb 24
8-K
NeuroPace Announces Preliminary Unaudited Revenue for Fourth Quarter and Full Year 2023 and Provides Business Updates
8 Jan 24
8-K
Entry into a Material Definitive Agreement
4 Dec 23
8-K
NeuroPace Reports Third Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance
6 Nov 23
8-K
NeuroPace Reports Second Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance
8 Aug 23
8-K
Departure of Directors or Certain Officers
19 Jul 23
8-K
Departure of Directors or Certain Officers
28 Jun 23
8-K
Submission of Matters to a Vote of Security Holders
12 Jun 23
8-K
NeuroPace Reports First Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance
4 May 23
Registration and prospectus
S-8
Registration of securities for employees
5 Mar 24
S-8
Registration of securities for employees
8 Aug 23
S-8
Registration of securities for employees
2 Mar 23
S-3
Shelf registration
8 Nov 22
S-8
Registration of securities for employees
10 Mar 22
S-8
Registration of securities for employees
23 Apr 21
424B4
Prospectus supplement with pricing info
23 Apr 21
S-1MEF
Registration of additional securities for an S-1
21 Apr 21
FWP
Free writing prospectus
21 Apr 21
POS AM
Prospectus update (post-effective amendment)
21 Apr 21
Other
EFFECT
Notice of effectiveness
23 Nov 22
EFFECT
Notice of effectiveness
22 Apr 21
EFFECT
Notice of effectiveness
21 Apr 21
CORRESP
Correspondence with SEC
21 Apr 21
CORRESP
Correspondence with SEC
21 Apr 21
CERT
Certification of approval for exchange listing
20 Apr 21
CORRESP
Correspondence with SEC
16 Apr 21
CORRESP
Correspondence with SEC
16 Apr 21
CORRESP
Correspondence with SEC
9 Apr 21
UPLOAD
Letter from SEC
7 Apr 21
Ownership
4
Change in insider ownership
18 Apr 24
4
Change in insider ownership
15 Apr 24
144
Notice of proposed sale of securities
15 Mar 24
4
Martha Morrell
28 Feb 24
4
Rebecca Kuhn
28 Feb 24
4
Joel Becker
28 Feb 24
SC 13G/A
ORBIMED ADVISORS LLC
14 Feb 24
SC 13G/A
KCK LTD.
14 Feb 24
SC 13G/A
MORGAN STANLEY
9 Feb 24
SC 13G/A
FMR LLC
9 Feb 24